These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8418619)

  • 1. Pregnancy in women with end-stage renal disease: treatment of anemia and premature labor.
    Hou S; Orlowski J; Pahl M; Ambrose S; Hussey M; Wong D
    Am J Kidney Dis; 1993 Jan; 21(1):16-22. PubMed ID: 8418619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anemia treatment with darbepoetin alpha in pregnant female with chronic renal failure: report of two cases.
    Sobiło-Jarek L; Popowska-Drojecka J; Muszytowski M; Wanic-Kossowska M; Kobelski M; Czekalski S
    Adv Med Sci; 2006; 51():309-11. PubMed ID: 17357331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoietin use in pregnancy: two cases and a review of the literature.
    Scott LL; Ramin SM; Richey M; Hanson J; Gilstrap LC
    Am J Perinatol; 1995 Jan; 12(1):22-4. PubMed ID: 7710570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anemia treatment with erythropoietin in pregnant renal recipients.
    Cyganek A; Pietrzak B; Kociszewska-Najman B; Sanko-Resmer J; Paczek L; Wielgos M
    Transplant Proc; 2011 Oct; 43(8):2970-2. PubMed ID: 21996203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficiency of recombinant human erythropoietin treatment in anemic pregnant women with a kidney transplant.
    Szurkowski M; Wiecek A; Kokot F; Daniel K
    Nephron; 1994; 67(2):242-3. PubMed ID: 8072619
    [No Abstract]   [Full Text] [Related]  

  • 6. Recombinant human erythropoietin in patients with anemia due to end-stage renal disease. US multicenter trials.
    Sobota JT
    Contrib Nephrol; 1989; 76():166-78; discussion 212-8. PubMed ID: 2684519
    [No Abstract]   [Full Text] [Related]  

  • 7. Erythropoietin in pregnancies complicated by severe anemia of renal failure.
    Yankowitz J; Piraino B; Laifer SA; Frassetto L; Gavin L; Kitzmiller JL; Crombleholme W
    Obstet Gynecol; 1992 Sep; 80(3 Pt 2):485-8. PubMed ID: 1495715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of blood pressure changes during recombinant human erythropoietin therapy.
    Levin N
    Semin Nephrol; 1989 Mar; 9(1 Suppl 2):16-20. PubMed ID: 2669081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease.
    Ifudu O; Feldman J; Friedman EA
    N Engl J Med; 1996 Feb; 334(7):420-5. PubMed ID: 8552143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Successful pregnancy in a patient with chronic renal failure undergoing haemodialysis].
    Furaz Czerpak KR; Puente García A; Corchete Prats E; Moreno MA; Martín Hernandez R
    Nefrologia; 2011; 31(2):219-21. PubMed ID: 21461018
    [No Abstract]   [Full Text] [Related]  

  • 11. Indomethacin in pregnancy: applications and safety.
    Abou-Ghannam G; Usta IM; Nassar AH
    Am J Perinatol; 2012 Mar; 29(3):175-86. PubMed ID: 21786219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anemia and erythropoietin in hemodialysis and continuous ambulatory peritoneal dialysis.
    Korbet SM
    Kidney Int Suppl; 1993 Feb; 40():S111-9. PubMed ID: 8445832
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of recombinant human erythropoietin treatment in end-stage renal failure patients. Results of a multicenter phase II/III study.
    Pollok M; Bommer J; Gurland HJ; Koch KM; Schoeppe W; Scigalla P; Baldamus CA
    Contrib Nephrol; 1989; 76():201-11; discussion 212-8. PubMed ID: 2684523
    [No Abstract]   [Full Text] [Related]  

  • 14. The efficacy of erythropoietin in human immunodeficiency virus-infected end-stage renal disease patients treated by maintenance hemodialysis.
    Shrivastava D; Rao TK; Sinert R; Khurana E; Lundin AP; Friedman EA
    Am J Kidney Dis; 1995 Jun; 25(6):904-9. PubMed ID: 7771487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy of renal anemia with recombinant human erythropoietin in children with end-stage renal disease.
    Scigalla P; Bonzel KE; Bulla M; Burghard R; Dippel J; Geisert J; Leumann E; von Lilien T; Müller-Wiefel DE; Offner G
    Contrib Nephrol; 1989; 76():227-40; discussion 240-1. PubMed ID: 2684524
    [No Abstract]   [Full Text] [Related]  

  • 16. Twin with hydramnios: treating premature labor at source.
    Lange IR; Harman CR; Ash KM; Manning FA; Menticoglou S
    Am J Obstet Gynecol; 1989 Mar; 160(3):552-7. PubMed ID: 2648831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to recombinant human erythropoietin (r-Hu EPO) and L-carnitine combination in patients with anemia of end-stage renal disease.
    Boran M; Dalva I; Gönenç F; Cetin S
    Nephron; 1996; 73(2):314-5. PubMed ID: 8773364
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of subcutaneous recombinant human erythropoietin in children undergoing continuous cycling peritoneal dialysis.
    Sinai-Trieman L; Salusky IB; Fine RN
    J Pediatr; 1989 Apr; 114(4 Pt 1):550-4. PubMed ID: 2926567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin treatment of erythropoietin-deficient anemia without renal disease during pregnancy.
    Harris SA; Payne G; Putman JM
    Obstet Gynecol; 1996 May; 87(5 Pt 2):812-4. PubMed ID: 8677097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dialysis dose, membrane type, and anemia control.
    Young EW
    Am J Kidney Dis; 1998 Dec; 32(6 Suppl 4):S157-60. PubMed ID: 9892384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.